key: cord-0024027-sgka5iuk
authors: Perez Rosero, Eliana; Heron, Samantha; Jovel, Juan; O’Neil, Conar R.; Turvey, Shannon Lee; Parashar, Pallavi; Elahi, Shokrollah
title: Differential Signature of the Microbiome and Neutrophils in the Oral Cavity of HIV-Infected Individuals
date: 2021-11-09
journal: Front Immunol
DOI: 10.3389/fimmu.2021.780910
sha: 7a3ca5ab6ddc6e8bb3afaa2856880604fb32e11e
doc_id: 24027
cord_uid: sgka5iuk

HIV infection is associated with a wide range of changes in microbial communities and immune cell components of the oral cavity. The purpose of this study was to evaluate the oral microbiome in relationship to oral neutrophils in HIV-infected compared to healthy individuals. We evaluated oral washes and saliva samples from HIV-infected individuals (n=52) and healthy controls (n=43). Using 16S-rRNA gene sequencing, we found differential β-diversity using Principal Coordinate Analysis (PCoA) with Bray-Curtis distances. The α-diversity analysis by Faith’s, Shannon, and observed OTUs indexes indicated that the saliva samples from HIV-infected individuals harbored significantly richer bacterial communities compared to the saliva samples from healthy individuals. Notably, we observed that five species of Spirochaeta including Spirochaetaceae, Spirochaeta, Treponema, Treponema amylovorum, and Treponema azotonutricum were significantly abundant. In contrast, Helicobacter species were significantly reduced in the saliva of HIV-infected individuals. Moreover, we found a significant reduction in the frequency of oral neutrophils in the oral cavity of HIV-infected individuals, which was positively related to their CD4(+) T cell count. In particular, we noted a significant decline in CD44 expressing neutrophils and the intensity of CD44 expression on oral neutrophils of HIV-infected individuals. This observation was supported by the elevation of soluble CD44 in the saliva of HIV-infected individuals. Overall, the core oral microbiome was distinguishable between HIV-infected individuals on antiretroviral therapy compared to the HIV-negative group. The observed reduction in oral neutrophils might likely be related to the low surface expression of CD44, resulting in a higher bacterial diversity and richness in HIV-infected individuals.

The oral cavity is a unique environment that comprises immune cells, soluble immune mediators, microbial communities, food antigens/foreign materials, soft and hard tissues (1, 2) . Although most of the research has been focused on bacterial communities, the oral cavity harbors a large collection of viruses, fungi, and bacteriophages (3) . Saliva flow, soluble salivary components such as antimicrobial peptides (4) , immune cells, and mucosal epithelial cells in cross-talk with oral microbiome work together to sustain an immune homeostatic state under normal physiological conditions (5, 6) . For example, SLPI (salivary secretory leukocyte protease inhibitor), defensins, sIgA, lactoferrin, and lysosome in the saliva play a protective role against viral infections (e.g. HIV) (7) . However, upon the acquisition of HIV infection and disease progression due to the elimination/reduction of HIV-target cells (CD4 + and Th17 cells) (7) (8) (9) , patients become prone to opportunistic infections such as candidiasis and other oral manifestations (e.g. Kaposi's sarcoma) (10, 11) . Notably, elimination of Th17 cells and reduction in IL-17 result in decreased recruitment of innate immune cells especially neutrophils into the oral cavity (12) . Besides, HIVinfected individuals with lower CD4 + T cell count even when on antiretroviral therapy (ART) exhibit decreased neutrophil frequency in their blood circulation (13) .

Neutrophils are the most abundant leukocytes in the blood circulation and also in the oral cavity (14) . The interaction of neutrophils with symbiotic microbial communities plays a crucial role in immune homeostasis at the mucosal surfaces such as the oral cavity (15) . However, dysbiotic microbiota at the mucosal surfaces (e.g. gingival crevice) activate neutrophils which results in an exacerbated inflammatory response (16) . The oral cavity is an important peripheral microenvironment for neutrophils given its richness with bacterial communities (17) . Additionally, bacterial communities can directly or indirectly (e.g. activation of macrophage, dendritic cells, and lymphocytes) influence neutrophil recruitment and activation in oral tissues (15, 18) . For example, germ-free mice have decreased neutrophils and their progenitors in the oral cavity compared to wild-type mice (19) . It has also been reported that bacterial communities enhance neutrophils aging (20) . As such, aged neutrophils exhibit an inflammatory phenotype by increased production of reactive oxygen species (ROS) (21) . Moreover, chronic conditions can influence microbial communities at the mucosal surfaces including the oral cavity. For example, diabetes can modify the oral microbiome to exacerbate periodontal disease (22) .On the other hand, the dysbiotic oral microbiome has been reported to be associated with colorectal and pancreatic cancers (23) (24) (25) . Nevertheless, the impact of HIV infection on the oral microbiome is controversial. Some studies support microbiome modifications, and some do not. These discrepancies could be related to various factors such as the study design, detection methods, and sampling (e.g., saliva, oral wash, or subgingival). For example, it was reported that HIV infection modulates oral fungi population and cigarette smoking in HIV-infected individuals was associated with greater microbial diversity (26) . It appears that HIV infection shifts oral microbial communities towards a dysbiotic state (27) . In particular, higher levels of cultivable microbes were isolated from the saliva of HIV-infected individuals compared to the HIVuninfected group (28, 29) . Other clinical variables are associated with alterations in the composition of oral microbial communities in HIV-infected individuals on ART (29) . Although the potential influence of ART on the oral microbiome is debatable, it is reported that ART partially reverses HIV-induced oral microbiota alteration (29) . ART treatment appeared to be associated with significantly greater bacterial richness and diversity (30) . These studies demonstrate that HIV infection and/or ART adds another layer of complexity to the tight interplay between the immune system and microbial communities in the oral cavity. However, the impact of HIV infection and/or microbial communities on oral neutrophils and vice versa have remained unexplored.

Neutrophils are crucial players in immune homeostasis in the oral cavity (31) . However, in inflammatory conditions such as periodontitis, the accumulation of activated neutrophils can result in tissue damage and bone loss (32) . The activation of circulatory neutrophils results in cellular polarization, which facilitates tissue extravasation (33) . CD44, a type I transmembrane glycoprotein, is one of the extracellular adhesion molecules that impacts neutrophil rolling and tissue migration (34) . As such, lack of CD44 was associated with decreased neutrophil migration to inflamed tissue in CD44 KO mice (35) . Besides, the interaction of CD44 with hyaluronate enhances neutrophil phagocytosis in vitro (36) . Recently, we reported that CD44 interacts with Galectin-9 (Gal-9) on blood neutrophils (37) . Gal-9 as a beta-galactosidase binding protein has a wide range of immunomodulatory properties depending on interaction with its corresponding receptors (38) . We found that CD44 depalmitoylate during neutrophil activation and facilitates the movement of CD44 out of the lipid raft, and subsequently Gal-9 shedding from neutrophils in HIV-infected individuals (37) . This process results in increased soluble plasma Gal-9 in HIV-infected individuals which subsequently enhances T cell activation via interaction with CD44 on T cells (37) . Therefore, Gal-9 shedding from neutrophils might explain a potential source for the elevated plasma Gal-9 in HIV-infected individuals (39) .

In the present study, we show that HIV-infected individuals have a different and richer bacterial composition in their saliva than healthy controls. Besides, we observed a significant reduction in the proportion of oral neutrophils in HIVinfected individuals, in particular, in those with lower CD4 + T cell count. Additionally, we observed downregulation of CD44 surface expression on oral neutrophils in HIV-infected individuals, which potentially explains their decreased frequency in the oral cavity of HIV infected-individuals.

For this study, we recruited sixty-one HIV-infected individuals including: a) on ART with low CD4 + T cell count (< 200 cells/mm 3 , n=11); b) on ART with high CD4 + count (>200 cells/mm 3 , n=40); c) Long-term non-progressors (40) (LTNPs, n=9) and d) ART-native, n=2) through the Northern Alberta HIV Program in Edmonton, Canada (Supplementary Tables 1, 2) . All the work presented in this manuscript was conducted on HIV-infected individuals receiving ART except Figures 2C, D, which compares the frequency of neutrophils in different HIVinfected groups. Also, a total of 43 healthy controls (HCs) defined as HIV, Hepatitis B virus, and Hepatitis C virus seronegative individuals without active oral disease were recruited at the University of Alberta for comparison. The institutional ethics review boards at the University of Alberta approved the study with the protocols (Pro00070528 and Pro000064046). All study participants gave written informed consent to participate in the study.

Participants avoided eating or drinking for at least 30 minutes before the sample collection. Saliva samples were obtained followed by oral washes from the study participants. Saliva samples were aliquoted and stored at -80°C until use.

Oral wash was performed 5 times using 15 ml of phosphatebuffered saline solution (PBS) for 30 seconds with 3 minutes' intermission between rinses. Samples were centrifuged at 2000 rpm for 10 min, supernatants were discarded, and cell pellets were resuspended in culture media (RPMI-1640) supplemented with 10% fetal bovine serum (FBS) (Sigma) and 1% penicillinstreptomycin (Sigma). Cell suspensions were filtered through 100, 70, and 50 mm sterile strainers (Fischer Scientific), centrifuged and resuspended in culture media for further analysis. Blood samples of 16 HCs and 15 HIV-infected individuals on ART were subjected to gradient separation using Ficoll-Paque Premium (GE). The peripheral blood mononuclear cell (PBMC) fraction was removed, and the remaining red blood cell pellet was lysed using red blood cell lysis buffer for 10 minutes (0.155M NH 4 Cl, 10mM KHCO 3 , and 0.1mM EDTA) to isolate polymorphonuclear cells according to our previous methods (37, 41) .

Fluorophore antibodies with specificity to antigens of human cells were purchased from BD Biosciences, Thermo Fisher Scientific, and/or R&D. We used anti-CD15 (clone W6D3, Cat#555402), anti-Gal-9 (clone 9M1-3, Cat#50-9116-42), anti-CD44 (clone 515, Cat#562890), anti-CD16 (clone 3G8, Cat#557744) and anti-CD32 (clone FLI8.26, Cat#744259). Cell viability was evaluated by LIVE/ DEAD Kit (ThermoFisher Scientific Cat#L34966). Apoptosis assay was performed using the PE Annexin V Apoptosis Detection Kit I (BD Biosciences Cat#55963) according to the manufacturer's protocol. Stained cells were fixed in 4% paraformaldehyde before acquiring on an LSRFortessa-SORP or LSRFortessa X-20 flow cytometers (BD Biosciences), and data were analyzed using the FlowJo (version 10).

The liquid fraction of the saliva was 2-fold diluted for cytokine quantification. We specifically measured TNF-a, IL-8, IL-6, IL-10, IL-13, IL-1B, IFN-g using V-plex Plus pro-inflammatory kit from Meso Scale Discovery (MSD Cat#K15054D-1), according to the manufacturer's instruction and our previous reports (41, 42) . Similarly, CD44 (R&D Systems; DY7045-05) and Gal-9 (R&D; DY 2045) concentrations were quantified by ELISA.

Chemotaxis was evaluated by the Cell Invasion Assay (Millipore Sigma, Cat. ECM 555). Blood neutrophils (n=10) and oral neutrophils (n=6) from HCs (n=10) were isolated and 0.5 million cells were used per well. Cells were pre-incubated in a 96 well plate with the anti-CD44 antibody (TermoFisher, Cat. 16-0441-85) at 37°C, for 30 min. Then cells were transported to the upper chamber of the migration assay and incubated in the presence or absence of soluble Galectin-9 (1.5 ng/ml) for 3 hours at 37°C. N-Formylmethionyl-leucyl-phenylalanine fMLP (50 mm, Sigma Aldrich, Cat. F3506-10MG) was used as a chemoattractant in the lower chamber. Culture media was used as the negative control. The migrated cells were lyzed and quantified by measuring the relative fluorescence units per manufacturing protocol using the plate reader a5 480/520 nm.

Saliva aliquots from sex and age paired participants were centrifuged and pellets were used for DNA isolation using the QIAamp DNA Mini Kit (Cat# 51304). Pellets were mixed with 20 ml of Proteinase K and 200 ml of in-house lysis buffer (100 mL of 0.5 M sodium chloride, 0.005 M tris aminomethane-pH8, 0.05M ethylenediaminetetraacetic acid with pH 8, and 4% sodium dodecyl sulfate), briefly vortexed, and incubated at 56°C water bath for 60 min, followed by 15 min incubation at 70°C. Then 200 ml of buffer AL (from the kit) was added for a final 10-minute incubation at 70°C, accompanied by DNA column extraction according to the manufacturer's instructions.

16SrRNA Illumina MiSeq Sequencing V3-V4 variable regions of 16S rRNA were amplified from genomic DNA samples. Amplicons were generated using the following primers: Forward Primer = 5' CGTCGGCAGC GTCAGATGTGTATAAGAGACAGCCTACGGGNGG CWGCAG and Reverse Primer = 5' TCTCGTGGGCTCGG AGATGTGTATAAGAGACAGGACTAC HVGGGTATCT AATCC (IDT). Thus, generated PCR products were indexed using Illumina's Nextera XT kit. Sequencing was performed on Illumina's MiSeq platform using a 250-bp paired-end sequencing kit at The Applied Genomic Core (TAGC), University of Alberta.

Sequencing data were demultiplexed and binned into individual samples according to their barcodes and further bioinformatic analysis was performed using the QIIME2 pipeline (2021.4). The first step of this analysis was to join the paired-end reads (1 and 2) with a minimum of 100 bp overlap and 0 mismatches. Reads were then quality filtered by removing sequences having more than 10 sites with a Phred quality score less than 20. Next, reads were denoised into amplicon sequence variants (ASVs) using the DADA method. Taxonomy classification at the phylum, family, and genus levels was done by comparing ASVs to the Green genes bacterial reference database (v. 13.5). Diversity indices (Evenness, Observed OTUs, Shannon's diversity, and Faith's phylogenetic index) and distances between samples (Bray-Curtis, weighted-and unweighted-Unifrac) were all calculated in QIIME2 to profile oral microbiota. Before taxonomy classification and generating alpha and beta diversity metrics, data were rarefied across samples for normalization such that all samples have the same number of total reads.

This was performed in GraphPad Prism 9 (GraphPad Software, Inc.). D'Agostino & Pearson test was used for normality check, being samples non-parametrical Mann-Whitney U tests for unpaired data or Wilcoxon signed-rank tests for paired data were used. When comparing more than two groups, the Kruskal Wallis test was used. Means and standard deviations (mean ± SD) are used to present the data. Correlation analysis was performed by nonparametric Spearman correlation.

We first compared the two groups in terms of b-diversity using Principal Coordinate Analysis (PCoA) with Bray-Curtis distances. The results indicated a differential clustering of bacterial communities in the saliva of HIV-infected compared to healthy individuals ( Figure 1A ). Distances within groups versus distances across groups were determined by ANOSIM, which was significant (P=0.001). ADONIS or differences between the group's centroid was also significant (P=0.003). The Alpha diversity analysis by Faith's, Shannon, and observed OTUs indexes showed that the saliva samples from HIV-infected individuals harbored significantly richer bacterial communities compared to the saliva samples from HCs ( Figure 1B) To further determine which bacterial communities were different between the groups, we compared them at different levels. At the phylum level, we found Spirochaetes' phylum was significantly enriched in the saliva samples of HIV-infected individuals compared to HCs ( Figures 1C, D) . When bacterial communities were compared at the species level ( Figure 1E ), we observed that five species of Spirochaeta including Spirochaetaceae, Spirochaeta, Treponema, Treponema amylovorum, and Treponema azotonutricum were significantly abundant in the saliva of HIV-infected individuals compared to HCs ( Figure 1F ). The volcano plot shows further differences in bacterial species among the groups. Species that were enriched in the saliva of HIV-infected individuals are shown in the right upper quadrant, and bacterial species that were less prevalent in the saliva of HIV-infected individuals are shown in the upper left quadrant of the volcano plot ( Figure 1G ). Bacterial species with mean counts less than 1 were not accounted for. We found that bacterial communities belonging to Spirochaetes, Bacteroidetes, Firmicutes, and TM7 species were significantly enriched in the saliva samples from HIV-infected individuals, respectively ( Figures 1H-J) . In contrast, we noted a significantly lower abundance of Proteobacteria phylum (in particular Helicobacter) in the saliva of HIV-infected individuals compared to HCs ( Figure 1K ). We used 97% sequence identity for binning analysis. Overall, our results show a significant difference in bacterial communities in the oral cavity of HIV-infected compared to uninfected individuals. To exclude potential effects of sex/age, saliva specimens were agesex-matched for the microbiome studies.

To better understand the possible role of immune components of the oral cavity in HIV-infected individuals on the bacterial composition, we focused on neutrophils as the most abundant immune cells in the oral cavity (43) . In agreement with previous reports, we found that neutrophils were the most abundant cells in the oral cavity. However, HIV-infected individuals had significantly lower percentages of neutrophils in their oral cavity compared to HCs (Figures 2A, B) . Both oral and blood neutrophils co-express CD15 and CD16 (Supplementary Figures 1A, B) . Notably, we observed significantly lower percentages of neutrophils in the oral cavity of ART-naive and patients on ART compared to HCs ( Figures 2C, D) . In contrast, we found a similar proportion of oral neutrophils in the oral cavity of HIV-infected LTNPs compared to HCs ( Figures 2C, D) . These observations suggest that the disease status may impact the frequency of neutrophils at the mucosal surfaces. Moreover, we did not find any significant difference in the frequency of other immune cells (e.g., dendritic cells, monocytes, and B cells) in the oral cavity of HIV-infected versus HCs except CD4 + T cells. Although, in general, the percentage of T cells was very low (a few %), we found significantly lower percentages of CD4 + T cells but not CD8 + T cells in the oral cavity of HIV-infected individuals compared to HCs (Supplementary Figures 1C-G) .

Recently, we showed that Gal-9 is downregulated from the surface of blood neutrophils in HIV-infected individuals compared to HCs (37) . Therefore, we decided to investigate whether this was the case for oral neutrophils. Our observations reconfirmed that the frequency of Gal-9 expressing blood neutrophils was significantly lower in HIV-infected individuals compared to HCs (Figures 2E, F) . However, we found a smaller portion of Gal-9 expressing oral neutrophils compared to their siblings in the blood, without any significant difference between the HIV-infected individuals on ART and HCs ( Figures 2E, F) . Moreover, we measured the intensity of Gal-9 and found that the Mean fluorescence intensity (MFI) of Gal-9 was significantly lower on the surface of blood neutrophils from HIV-infected individuals ( Figures 2G, H) . However, this was not the case for the oral neutrophils ( Figures 2G, H) . We also quantified the concentration of soluble Gal-9 in the plasma and saliva samples.

Although soluble Gal-9 was significantly elevated in the plasma of HIV-infected individuals as we have reported elsewhere (39), we did not find any difference in the soluble Gal-9 levels in the saliva between the groups ( Figure 2I ). Since Gal-9 has been reported as a contributing factor to the cytokine storm in COVID-19 patients (41), we reasoned to evaluate the correlation of saliva Gal-9 levels with proinflammatory cytokines. We found that Gal-9 levels were positively correlated with IL-6 in the saliva ( Figure 2J ). This may suggest the potential role of soluble Gal-9 in the activation status of neutrophils in the oral cavity of HIV-infected individuals. However, this was not the case for other quantified pro-inflammatory cytokines (e.g., IL-1b, IL-8, TNF-a and IFN-g) in the saliva.

Oral Neutrophils Less Apoptotic IL-6 has been related to increased neutrophil survival (44) and an activated status can prolong the lifespan of neutrophils (45) . Thus, we decided to investigate differences in Gal-9+ versus Gal-9-oral neutrophils. Recently, we have reported that stimulation of blood neutrophils with LPS results in the downregulation of Gal-9 at the gene and protein levels (37) . Thus, we proposed that activated neutrophils lose their surface Gal-9, which in turn increases their lifespan. Indeed, we found that in HCs and HIVinfected individuals, neutrophils that did have surface Gal-9 were less apoptotic compared to their Gal-9 expressing counterparts ( Figures 2K, L) . These observations suggest that the downregulation of Gal-9 may act as a mechanism of enhanced neutrophil survival.

Unstimulated blood neutrophils express high levels of surface Gal-9 which is bound to CD44 (37) . Therefore, we decided to determine whether the same pattern exists for oral neutrophils. Similar to our previous finding, we found all blood neutrophils expressed CD44, however, this was about 50% for oral neutrophils ( Figure 3A) . Interestingly, we observed that the percentage of CD44 expressing neutrophils was significantly lower in the oral cavity of HIV-infected individuals ( Figures 3A, B) . Moreover, we found a significant reduction in the intensity of CD44 expression on oral neutrophils from HIVinfected individuals versus HCs (Figures 3C, D) . When the expression of CD44 in the blood and oral neutrophils was analyzed, we found a lower frequency of CD44 expressing neutrophils and even CD44 expression level on oral neutrophils compared to their counterparts in the blood in both HCs and HIV-infected individuals ( Figures 3E-G) . These observations led us to measure the soluble CD44 concentration in the saliva, which showed a significant elevation of CD44 levels in the saliva of HIV-infected compared to healthy individuals ( Figure 3H ). This might explain that oral neutrophils in HIVinfected individuals shed CD44 that can be detected in their saliva. Moreover, we found that the soluble Gal-9 promotes the migration of blood neutrophils in vitro ( Figure 3I ). In particular, we observed that this effect was CD44 dependent as the preincubation of neutrophils with the anti-CD44 antibody abrogated this effect ( Figure 3I ). Although a similar trend was observed for Gal-9 on neutrophils from the oral cavity, this effect did not reach a significant level (Supplementary Figure 1H) . Therefore, these findings may suggest that CD44 in the blood is upregulated to facilitate neutrophil migration into peripheral tissues, but once they reach their action site it is downregulated to keep neutrophils in their destination.

To further understand the possible role of soluble CD44 in the oral cavity, we found that it was positively correlated with saliva proinflammatory cytokines IL-6 and IL-8 in HIV-infected individuals ( Figures 3J, K) . Remarkably, we noted a positive correlation between the soluble CD44 with Faith's bacterial diversity index in HIV-infected individuals ( Figure 3L ). To further delineate the correlation between neutrophils and the oral microbiome, we measured the frequency of CD44 expressing neutrophils and the intensity of CD44 expression on oral neutrophils from HIVinfected versus HCs that were subjected to the microbiome analysis. We found that oral neutrophils had a significantly lower proportion and expression level of CD44 compared to their counterparts in HCs ( Figures 3M, N) . These observations suggest that microbial-derived molecules and/or other factors in the oral cavity may influence the expression of CD44 in HIVinfected individuals.

To further determine the activation status of neutrophils, we measured the expression of CD32. We found that CD32 was significantly upregulated in oral neutrophils of HIV-infected compared to healthy individuals ( Figures 4A-C ). CD32 has been described to participate in the interaction of neutrophils and uptake of IgG-opsonized viral particles (46) . Thus, we decided to investigate whether aged oral neutrophils expressing CD44 had different CD32 expressions compared to CD44negative counterparts. We found that CD44 + oral neutrophils had significantly a higher expression of CD32 compared to their CD44counterparts in both HIV-infected and healthy individuals ( Figure 4D ). In addition, we noted that although CD44 + neutrophils were more activated, both CD44 + and CD44neutrophils in HIV-infected individuals had significantly higher expression of CD32 compared to their counterparts in HCs ( Figures 4E-G) . These results suggest that neutrophils in the oral cavity of HIV-infected individuals have an activated phenotype compared to their counterparts in HCs.

To better understand whether observed changes were associated with other variables in both groups, we examined their sex, age, medications, oral health (brushing, flossing, using mouthwash), and other habits (smoking, alcohol, and recreational drug use) into our analysis (Supplementary Table 3 ). We found that groups were differently distributed based on their sex (P=0.028) ( Figure 5A ). While HCs consisted of 16 Males and 27 females, the HIV cohort was composed of 37 males and 24 females. In terms of age, for statistical analysis the Fischer exact test was applied that showed age was also different between groups (P= 0.027). HCs had more participants <50 years compared to HIV-infected individuals who were 50 < years old ( Figure 5B ). Excluding LTNPs and naïve patients, the rest of HIV-infected individuals were receiving ART. Also, some HIVinfected individuals (n=33) had other comorbidities (mainly diabetes, high cholesterol, and blood pressure, rheumatoid arthritis, anxiety-depression, and chronic pain). In contrast, a small portion of HIV-uninfected participants (n=13) had underlying conditions and were receiving related medications at the time of examination. Also, the participant's had differences in their habits as was analyzed by Fischer's exact test. The HIV-infected group had a significantly higher number of smokers compared to HCs (P < 0.0001). The same pattern was true for recreational drug/ cannabis in HIV-infected individuals compared to HCs (P=0.002) ( Figure 5C ). However, alcohol consumption was similar between the groups ( Figure 5C ). Regarding oral health, HIV-infected individuals flossed less often compared to HCs (P= 0.0001) ( Figure 5C ). In terms of brushing, mouthwash use, and the self-reported evaluation for bleeding on brushing (a tool for periodontitis risk prediction), we did not find any difference between the groups ( Figure 5C ). Finally, we correlated the proportion of neutrophils in oral washes (CD15 + cells) with habit practices in HIV-infected versus HCs. We found that HCs tend to have more neutrophils in their oral wash compared to HIV-infected individuals regardless of their habits ( Figure 5D) . Also, we noted that alcohol consumption, daily brushing, mouthwash use, and flossing significantly impacted neutrophil % in HCs vs HIV-infected individuals. Of note, the self-report for bleeding on brushing did not impact neutrophil percentages in the oral wash.

In this study, we investigated microbial communities in the saliva of HIV-infected and age-sex-matched HCs. We found differential bacterial compositions in the saliva of HIV-infected compared to healthy individuals. Our results are in agreement with another report that demonstrated differential bacterial clusters in the oral washes of a larger cohort of HIV-infected individuals versus HCs regardless of other contributing factors (e.g. smoking, missing teeth, gingivitis, candida infection, etc.) (29) . We observed differences in bacterial a-diversity (e.g., Shannon and Faith's indexes) and bacterial richness, which supports HIV-associated salivary dysbiosis. Although previous work investigated dysbiosis of the tongue (47) and periodontal tissues in HIV-infected individuals (48) , our results support that saliva expectoration provides a non-invasive, less expensive, and informative approach for oral cavity microbiome-related studies. In addition to microbiome studies, our study bridges the correlation between HIV-immune status, oral soluble mediators, and oral neutrophils. In a previous work, major difference in the phyla of Bacteroidetes, Firmicutes, Proteobacteria and TM7 in the saliva of HIV-infected individuals versus HCs has been documented (49). Our results were somewhat similar in identifying increases in oral Spirochaetes, Bacteroidetes, Firmicutes, and TM7 in HIV-infected individuals. Such differential oral microbiome composition may be related to systemic inflammation and impaired pulmonary function in HIV-infected individuals as a contributing factor to chronic obstructive pulmonary disease (COPD) (50) . Since all of our study subjects for the oral microbiome-related studies were on ART, we were unable to investigate the potential effects of ART on the oral microbiome. However, it was reported that the dysbiotic oral microbiome was not fully restored after effective ART, although some microbiota were restored (51) . Furthermore, ART, viral load, and CD4 + T cell count differentially contribute to salivary dysbiosis resulting in reduced or increased different bacterial species (27) . It is difficult to differentiate between various factors without longitudinal studies pre-infection, pre-ART, the type of ART regimens, and well-matched HIV-infected untreated controls sampling. In general, oral health, habits such as smoking, and drinking may influence the oral microbial communities. Although in our cohort we did not observe any difference between the HIVinfected vs. the control group in terms of periodontitis, higher bacterial diversity and richness have been reported in HIV-infected individuals with severe periodontitis (52) . Therefore, oral health can have direct effects on the microbial communities as increased bacterial diversity and richness have been associated with periodontal disease (53) . Prior work also reported gingival bleeding, decayed teeth, periodontal pockets, and smoking habits as important contributing factor to oral dysbiosis (54) . In our study, we observed that the HIV-infected group was more enriched with smokers, people who use recreational drug, and individuals who had poor adherence to oral health. These factors may influence the general oral health and subsequently the microbial composition of the oral cavity. For example, smoking has been associated with alteration in the oral microbiome. In particular, it has been reported that smoking enhances bacterial colonization in the upper respiratory tract in HCs, and even more pronounced in HIVinfected individuals (50, 55) .

Although a greater abundance of streptococcus mutants, lactobacillus, and candida species has been in the saliva of HIV-infected individuals (47), we did not find such differences. Instead, we discovered significantly higher abundance of Spirochaetes (Spirochaetacea, Spirochaeta, and Treponema), Porphyromonadaceae, Prevotella, Elizabethkingia, TM7 in the saliva of HIV-infected individuals. These observations are in agreement with a report showing an increased abundance of Prevotella in HIV-infected individuals (27) . Similarly, an increase in Porphyromonadaceae in the saliva of HIV-infected individuals was reported at the start of ART when compared to 24 weeks later (30) . Interestingly, the Porphyromonadaceae family harbors the well know periodontal pathogens Phorphyromona gingivalis and Tannerella Forsythia (56, 57) . It is reported that Phorphyromona gingivalis partners with HIV-virus to co-infect mucosal epithelial cells, in vitro (58) . Based on this observation, the abundance of Phorphyormonas in the oral cavity may facilitate HIV acquisition at the mucosal sites. However, further studies are required to support this hypothesis. TM7-RS-045 or Saccharibacteria is a recently discovered commensal oral bacteria that abides at the expense of Actynomices bacteria, however, its role in the oral cavity is not well defined (59) . In our cohort, we observed an increase of TM7, although we did not observe any difference in the abundance of Actinomyces species. A previous study, in support of our results, reported a higher abundance of TM7, Treponema, and Prevotella in the oral washes of HIV-infected individuals (29) . Particularly, Treponema denticola associated with Porphyromonas gingivalis, and Tanerella forsythia form the "red complex", which are the main pathogenic bacteria involved in periodontitis (60, 61) (53). Therefore, consistently our data suggest that HIV-infected individuals have increased bacterial communities associated with periodontal conditions. Besides, Prevotella is reported to be more abundant in the gastrointestinal tract (GI) of men who have sex with men (62) . The GI microbiome can be altered by different types of sexual practices. For example, men who have sex with men present a distinct GI microbiome composition when compared to men who have sex with women (63, 64) . Therefore, the type of sexual practice may influence the GI and oral microbiome composition. Although we did not obtain such information from our study subjects, we had a mixed population of males/females for the microbiome analysis. Furthermore, a higher abundance of Prevotella is related to a lower abundance of Th17 cells and IFN-I genes expression in the GI of HIV-infected individuals (65) . Moreover, the presence of Prevotella is associated with increased HIV acquisition in the genital tract (66). We found Elizabethkingia was another abundant bacteria in the saliva of HIV-infected individuals. Elizabethkingia is a multidrugresistant bacteria associated with life-threatening infections in immunocompromised individuals (67) . Thus, the presence of bacterial species like Porphyromonadacea and Elizabethkingia in the saliva of HIV-infected individuals may predispose them to such bacterial infections.

On the other hand, we found that Helicobacter was significantly decreased in the saliva of HIV-infected individuals. The presence of Helicobacter pillory in the dental plaque of HIV-infected individuals with H. pillory-induced gastritis has been reported (68, 69) . However, its correlation with the stomach infection has been challenged (70) despite reports that the oral cavity should be considered as the secondary site for its colonization (71) . However, our results are in agreement with another report that indicated the reduced frequency of H. papillary-induced gastric infection in HIV-infected individuals (72) .

Our further analysis in understanding the immune components of the oral cavity in HIV-infected individuals demonstrated a significant decrease in the proportion of oral neutrophils which was associated with disease progression (e.g., CD4 + T cell count). Notably, LTNPs exhibited the same frequency of neutrophils in their oral cavity compared to HCs. This observation provides another novel insight into the uniqueness of this rare group of HIV-infected individuals as we have reported elsewhere (73) (74) (75) . Therefore, considering the crucial role of oral neutrophils in immune homeostasis in the oral cavity, their lower frequency may predispose HIV-infected individuals to opportunistic infections. As such, it is possible to speculate that decreased frequency of oral neutrophils in individuals with lower CD4 + T cell count may reflect the depletion of Th17 cells at their mucosal sites (76) . Subsequently, a lower Th17 cell population reduces neutrophils' recruitment to the oral cavity. On the other hand, lower Th17 cells at the mucosal sites of the oral cavity may predispose HIV-infected individuals to oral candidiasis, considering the protective role of IL-17 against Candida albicans (77) . Although we were unable to investigate the cross-talk between neutrophils and the oral microbiome, the salivary increase of Treponema species may potentially be related to neutrophil dysfunction in HIV-infected individuals (78) . Deficiency in neutrophils chemotaxis and polarization in HIVinfected individuals (79) might explain another reason for reduced neutrophil frequency in HIV-infected individuals. On a supporting note, we observed significantly reduced expression and frequency of CD44 + neutrophils in the oral cavity of HIV-infected individuals. CD44 is expressed on neutrophils and contributes to neutrophil crawling and extravasation (35) . Therefore, lower CD44 expression on neutrophils from HIV-infected individuals may provide another underlying mechanism for their impairment. Subsequently, we found elevated levels of soluble CD44 in the saliva of HIVinfected individuals compared to HCs. The role of soluble CD44 in the saliva of HIV-infected individuals is still unknown and required further investigation. However, the salivary CD44 appears to be a surrogate marker in detection of head and neck squamous cell carcinoma (HNSCC) (80) . Of note, we found a positive correlation between soluble CD44 and IL-6 in the saliva of HIV-infected individuals.

IL-6 has been reported as exhibiting both pro-and antiinflammatory functions. Certain protective aspects of IL-6 influence leukocyte migration such as prevention of neutrophil accumulation at the site of inflammation/infection (81, 82) . As such, exposure of IL-6 deficient mice to respiratory endotoxin resulted in a higher number of neutrophil accumulation in their lungs compared to wild-type mice (81) .

Therefore, it is possible to suggest that the saliva level of IL-6 may influence neutrophil recruitment to the oral cavity as it enhances neutrophil egress (83) . On the other hand, we found that Gal-9 interaction with CD44 enhances neutrophil migration in vitro. However, Gal-9 appears to exhibit different effects on neutrophil chemotaxis. For example, Gal-9 deficient mice experienced reduced neutrophil response to respiratory infection (84) . In contrast, increased neutrophil infiltration following ischemic injury in Gal-9 deficient mice has been reported (85) . Although Gal-9 may regulate neutrophil infiltration at the site of inflammation by modulating regulatory T cells and Th17 cells (86) , our observations support that Gal-9 via interaction with CD44 enhances neutrophil migration. Finally, the association between the saliva CD44 levels and the microbial Faith's diversity suggests a cross-talk between neutrophils and the composition/abundance of microbial communities in the oral cavity.

We are aware of many study limitations that may have influenced our results. Although we attempted to have age-sexmatched study subjects, due to the COVID-19 pandemic we had limited options in terms of access to study cohorts. We also noted a higher prevalence of cigarette smoking, people with substance use disorder, and individual with poor oral health in the HIV-infected group, which might have influenced our results. Moreover, we were unable to analyze the impact of ART on neutrophils and/or microbiome in our cohort because all of our study subjects were on ART. Also, HIV-infected individuals had more underlying conditions compared to the HCs. However, for the microbiome studies we selected subjects without major underlying health conditions apart from HIV infection. Finally, due to a very low cell yield in the oral washes, we were unable to perform functional studies to better characterize oral neutrophil functions compared to their counterparts in the blood.

In summary, our data provide a novel insight into the impact of HIV infection on oral neutrophils. In particular, we discovered that oral neutrophils in HIV-infected individuals have significantly higher expression of CD32 but lower expression of CD44. The influence of Gal-9:CD44 on neutrophil migration highlights an important role for Gal-9 in neutrophil movement. Thus, the lower frequency of neutrophils in the oral cavity of HIV-infected individuals could be explained by the downregulation of CD44 expression. More importantly, we found elevated levels of soluble salivary CD44 which was positively correlated with Faith's diversity of the microbiome.

Overall, our results support the differential oral microbiome diversity and richness in HIV-infected individuals. Although further studies in larger cohorts are required, our results provide a novel insight into the immune-microbiota relationship in the oral cavity.

The original contributions presented in the study are publiclyavailable. This data can be found here: https://www. ncbi.nlm.nih.gov/, PRJNA766045.

The studies involving human participants were reviewed and approved by the human ethics board at the University of Alberta. The patients/participants provided their written informed consent to participate in this study.

ER performed most of the immunological and microbiome related experiments, analyzed the data and wrote the first draft. SH performed some of the experiments. JJ assisted with 16S rRNA data analysis. CO'N and ST recruited HIV-infected individuals for the study. PP provided resources and scientific advice. SE conceived the original idea, designed and supervised all of the research, assisted in data analysis and re-wrote the manuscript. All authors contributed to the article and approved the submitted version.

This study was supported by a Foundation Grant from the Canadian Institutes of Health Research (CIHR) and a CIHR New Investigator Salary Award (both to SE).

The Oral Mucosa: A Barrier Site Participating in Tissue-Specific and Systemic Immunity

The Human Oral Microbiome

Ecology of the Oral Microbiome: Beyond Bacteria

The Host Defense Peptide Beta-Defensin 1 Confers Protection Against Bordetella Pertussis in Newborn Piglets

Oral Mucosal Immunity and HIV/SIV Infection

Oral Mucosal Immunity. Oral Surg Oral Med Oral Pathol Oral Radiol

HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation

Immune Activation, Inflammation, and Non-AIDS Co-Morbidities in HIV-Infected Patients Under Long-Term ART

Mucosal Regulatory T Cells and T Helper 17 Cells in HIV-Associated Immune Activation

Oral Manifestations of HIV: Can They be an Indicator of Disease Severity? (A Systematic Review)

Oral Innate Immunity in HIV Infection in HAART Era

IL-17: Overview and Role in Oral Immunity and Microbiome

Neutropenia in Human Immunodeficiency Virus Infection: Data From the Women's Interagency HIV Study

Oral Neutrophils Characterized: Chemotactic, Phagocytic, and Neutrophil Extracellular Trap (NET) Formation Properties

Cross Talk Between Neutrophils and the Microbiota

Immunomicrobial Pathogenesis of Periodontitis: Keystones, Pathobionts, and Host Response

The Neutrophil: Constant Defender and First Responder

Human Neutrophils and Oral Microbiota: A Constant Tug-of-War Between a Harmonious and a Discordant Coexistence

The Microbiota Regulates Neutrophil Homeostasis and Host Resistance to Escherichia Coli K1 Sepsis in Neonatal Mice

Neutrophil Ageing Is Regulated by the Microbiome

Aging: A Temporal Dimension for Neutrophils

Diabetes Enhances IL-17 Expression and Alters the Oral Microbiome to Increase Its Pathogenicity

Metabolic and Community Synergy of Oral Bacteria in Colorectal Cancer. mSphere

Medical Hypothesis Oral Bacteria in Pancreatic Cancer: Mutagenesis of the P53 Tumour Suppressor Gene

Oral Bacteria and Cancer

Dysbiosis in the Oral Bacterial and Fungal Microbiome of HIV-Infected Subjects Is Associated With Clinical and Immunologic Variables of HIV Infection

Oral Microbiome in HIV-Infected Women: Shifts in the Abundance of Pathogenic and Beneficial Bacteria Are Associated With Aging, HIV Load, CD4 Count, and Antiretroviral Therapy

HIV Infection and Microbial Diversity in Saliva

Significant Effect of HIV/HAART on Oral Microbiota Using Multivariate Analysis

Alterations in the Oral Microbiome in HIV-Infected Participants After Antiretroviral Therapy Administration Are Influenced by Immune Status

Neutrophils in Periodontal Inflammation

Microbial Shift and Periodontitis

Analysis of Neutrophil Polarization and Chemotaxis

Interactions Between CD44 and Hyaluronan in Leukocyte Trafficking

Role of CD44 and Hyaluronan in Neutrophil Recruitment

Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via P38-and ERK1/2-MAPK Signalling Pathways

Neutrophils Promote T-Cell Activation Through the Regulated Release of CD44-Bound Galectin-9 From the Cell Surface During HIV Infection

The Bitter Side of Sweet: The Role of Galectin-9 in Immunopathogenesis of Viral Infections

Galectin-9 Binding to Tim-3 Renders Activated Human CD4+ T Cells Less Susceptible to HIV-1

Galectin-9 and VISTA Expression Define Terminally Exhausted T Cells in HIV-1 Infection

Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection

Expanded Antigen-Experienced CD160+CD8+effector T Cells Exhibit Impaired Effector Functions in Chronic Lymphocytic Leukemia

Oral Polymorphonuclear Neutrophil Characteristics in Relation to Oral Health: A Cross-Sectional, Observational Clinical Study

In Vivo Interleukin-6 Protects Neutrophils From Apoptosis in Osteomyelitis

The Role of TLRs in Neutrophil Activation

Neutrophils Interact With Adenovirus Vectors via Fc Receptors and Complement Receptor 1

Evidence of an Increased Pathogenic Footprint in the Lingual Microbiome of Untreated HIV Infected Patients

Subgingival Plaque Microbiota in HIV Positive Patients

Modulation of the Orodigestive Tract Microbiome in HIV-Infected Patients

Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function

Altered Salivary Microbiome in the Early Stage of Hiv Infections Among Young Chinese Men Who Have Sex With Men (Msm)

Oral Microbiome in HIV-Associated Periodontitis

The Oral Microbiota: Dynamic Communities and Host Interactions

Bacterial Diversity in Saliva and Oral Health-Related Conditions: The Hisayama Study

The Respiratory Microbiome of HIV-Infected Individuals

Interconnections Between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance Between Systemic Health and Disease. Microorganisms

Human Microbiome and HIV/AIDS

Porphyromonas Gingivalis-Mediated Epithelial Cell Entry of HIV-1

Saccharibacteria (TM7) in the Human Oral Microbiome

The Role of the Microbiota in Periodontal Disease

Periodontitis: A Polymicrobial Disruption of Host Homeostasis

HIV-Associated Gut Dysbiosis is Independent of Sexual Practice and Correlates With Noncommunicable Diseases

An Exploration of Prevotella-Rich Microbiomes in HIV and Men Who Have Sex With Men

Gut Microbiota Linked to Sexual Preference and HIV Infection

High Abundance of Genus Prevotella Is Associated With Dysregulation of IFN-I and T Cell Response in HIV-1-Infected Patients

The Vaginal Microbiota and Susceptibility to HIV

Elizabethkingia Infections in Humans: From Genomics to

The Investigation of Helicobacter Pylori in the Dental Biofilm and Saliva Samples of Children With Dyspeptic Complaints. BMC Oral Heal

Is the Presence of Helicobacter Pylori in the Dental Plaque of Patients With Chronic Periodontitis a Risk Factor for Gastric Infection?

Analysis of by High-Throughput Sequencing: Helicobacter Pylori Infection and Salivary Microbiome

Helicobacter Pylori Colonization of the Oral Cavity: A Milestone Discovery

Helicobacter Pylori Gastritis in HIV-Infected Patients: A Review

Protective HIV-Specific CD8+ T Cells Evade T Reg Cell Suppression

Association of HLA-Alleles With the Immune Regulation of Chronic Viral Infections

Selective Upregulation of CTLA-4 on CD8+ T Cells Restricted by HLA-B*35Px Renders Them to an Exhausted Phenotype in HIV-1 Infection

Th17 Cells and HIV Infection

IL-17 Signaling in Host Defense Against Candida Albicans

The Msp Protein of Treponema Denticola Interrupts Activity of Phosphoinositide Processing in Neutrophils

Intracellular Signalling During Neutrophil Recruitment

Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer

IL-6 is an Antiinflammatory Cytokine Required for Controlling Local or Systemic Acute Inflammatory Responses

Protective Role of Interleukin 6 in the Lipopolysaccharide-Galactosamine Septic Shock Model

Interleukin-6 Mediates Neutrophil Mobilization From Bone Marrow in Pulmonary Hypertension

Alarmin Function of Galectin-9 in Murine Respiratory Tularemia

The Protective Function of Galectin-9 in Liver Ischemia and Reperfusion Injury in Mice

The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function

Conflict of Interest: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

The authors would like to thank the University of Alberta Faculty of Medicine and Dentistry's Flow cytometry facility, which has received financial support from the faculty of Medicine and Dentistry and the Canadian Foundation for Innovation (CFI) awards to contributing investigators. We also thank HIV-infected individuals from the Northern Alberta HIV program, and healthy individuals for their invaluable contribution to this study.

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2021. 780910/full#supplementary-material